Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Retained Earnings (2021 - 2026)

Bioventus filings provide 5 years of Retained Earnings readings, the most recent being -$1.9 million for Q4 2025.

  • On a quarterly basis, Retained Earnings rose 99.47% to -$1.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.9 million, a 99.47% increase, with the full-year FY2025 number at -$1.9 million, up 99.47% from a year prior.
  • Retained Earnings hit -$1.9 million in Q4 2025 for Bioventus, down from -$1.8 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $655000.0 in Q3 2023 to a low of -$360.3 million in Q1 2025.
  • Median Retained Earnings over the past 5 years was -$1.9 million (2025), compared with a mean of -$102.7 million.
  • Biggest five-year swings in Retained Earnings: soared 102.61% in 2023 and later crashed 110960.92% in 2025.
  • Bioventus' Retained Earnings stood at $179000.0 in 2021, then tumbled by 92449.72% to -$165.3 million in 2022, then tumbled by 94.51% to -$321.5 million in 2023, then dropped by 11.24% to -$357.7 million in 2024, then soared by 99.47% to -$1.9 million in 2025.
  • The last three reported values for Retained Earnings were -$1.9 million (Q4 2025), -$1.8 million (Q3 2025), and -$774000.0 (Q2 2025) per Business Quant data.